CONMED Corp. buy Piper Sandler
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€91.97
Performance (%)
-10.97%
End price
02.02.25
€69.00
Summary
This prediction ended on 02.02.25 with a price of €69.00. The price of CONMED Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.97%. Piper_Sandler has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. Dividends of €0.74 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 3.247% | 3.247% | -43.214% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,95 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 9,58 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 20,32 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 5,80 % |
Comments by Piper_Sandler for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $130.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten